ASPIRIN FOR CARDIOVASCULAR DISEASE PREVENTION AMONG ADULTS IN THE UNITED STATES: TRENDS, PREVALENCE, AND PARTICIPANT CHARACTERISTICS ASSOCIATED WITH USE

Código QR

ASPIRIN FOR CARDIOVASCULAR DISEASE PREVENTION AMONG ADULTS IN THE UNITED STATES: TRENDS, PREVALENCE, AND PARTICIPANT CHARACTERISTICS ASSOCIATED WITH USE

Guardado en:

Detalles Bibliográficos
Autores principales:	Ellen Boakye, Iftekhar Uddin, Olufunmilayo H. Obisesan, Albert D. Osei, Omar Dzaye, Garima Sharma, John W. McEvoy, Roger S. Blumenthal, Michael J. Blaha
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701 Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/87ac42ce084c4b3bb3573c5f37b756f0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Electronic Cigarettes and Cardiovascular Risk: Science, Policy and the Cost of Certainty
por: Olusola A Orimoloye, et al.
Publicado: (2019)

Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly
por: Sydney B Long, et al.
Publicado: (2010)

Prevalence of cardiovascular risk factors, the use of statins and of aspirin in Takayasu Arteritis
por: Charlotte Laurent, et al.
Publicado: (2021)

Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018
por: Mikkel B. Christensen, et al.
Publicado: (2021)

Excess Mortality in Aspirin and Dipyrone (Metamizole) Co‐Medicated in Patients With Cardiovascular Disease: A Nationwide Study
por: Amin Polzin, et al.
Publicado: (2021)

Trends in cardiovascular medicine
Publicado: (1991)

The impact of endoscopic sinus surgery and aspirin desensitization on psychological burden in aspirin-exacerbated respiratory disease
por: Tran Locke, et al.
Publicado: (2020)

The effect of aspirin nanoemulsion on TNFα and iNOS in gastric tissue in comparison with conventional aspirin
por: Mahmoud FA, et al.
Publicado: (2015)

Systematic review of outcomes for endoscopic sinus surgery and subsequent aspirin desensitization in aspirin-exacerbated respiratory disease
por: Lindsey Ryan, et al.
Publicado: (2020)

Aspirin for the Primary Prophylaxis of Colorectal Cancer
por: Kamran B Lankarani
Publicado: (2013)

Effect of Aspirin on the Developing Teeth of Neonates
por: Nazir,Shakila, et al.
Publicado: (2011)

Low-dose aspirin for primary prevention of cardiovascular events in postmenopausal women with type-2 diabetes: The prescriptive approach in the real world
por: Maria Maiello, et al.
Publicado: (2021)

Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance
por: S. Tommasi, et al.
Publicado: (2017)

Hepatocellular Carcinoma Prevention by Aspirin: Are Platelets the Link?
por: Hans Dieter Nischalke, et al.
Publicado: (2021)

Orthostatic Hypotension and Risk of Clinical and Subclinical Cardiovascular Disease in Middle‐Aged Adults
por: Stephen P. Juraschek, et al.
Publicado: (2018)

Appropriate extent of surgery for aspirin-exacerbated respiratory disease
por: Ethan G. Muhonen, et al.
Publicado: (2020)

Low-dose aspirin as treatment for central serous chorioretinopathy
por: Antonio Caccavale, et al.
Publicado: (2010)

Aspirin-exacerbated respiratory disease: Update on medical management
por: Andrew A. White, et al.
Publicado: (2020)

Pathogenesis of NSAID-induced reactions in aspirin-exacerbated respiratory disease
por: Tanya M. Laidlaw
Publicado: (2018)

The impact of aspirin on Klebsiella pneumoniae liver abscess in diabetic patients
por: Chien-Hsiang Tai, et al.
Publicado: (2020)

Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum
por: Caitlin A. Brennan, et al.
Publicado: (2021)

Low-dose aspirin was associated with an increased risk of cardiovascular events in patients with chronic kidney disease patients and low bodyweight: results from KNOW-CKD study
por: Yun Jung Oh, et al.
Publicado: (2021)

Effect of aspirin treatment duration on clinical outcomes in acute coronary syndrome patients with early aspirin discontinuation and received P2Y12 inhibitor monotherapy.
por: Ming-Yun Ho, et al.
Publicado: (2021)

Trends in Developing Corporate Management in Companies with State Participation in the Russian Federation
por: P. G. Vorontsov
Publicado: (2019)

Trending cardiac biomarkers during pregnancy in women with cardiovascular disease
por: Soohyun Chang, et al.
Publicado: (2021)

Aspirin and low-molecular weight heparin combination therapy effectively prevents recurrent miscarriage in hyperhomocysteinemic women.
por: Pratip Chakraborty, et al.
Publicado: (2013)

The Novel Aspirin as Breakthrough Drug for COVID-19: A Narrative Review
por: Bamidele Johnson Alegbeleye, et al.
Publicado: (2020)

Aspirin using was associated with slower cognitive decline in patients with Alzheimer's disease.
por: Jinyan Weng, et al.
Publicado: (2021)

A prospective study of aspirin use and the risk of gastrointestinal bleeding in men.
por: Edward S Huang, et al.
Publicado: (2010)

Micro Hardness of Dental Tissues Influenced by Administration of Aspirin During Pregnancy
por: Shakila,Nazir, et al.
Publicado: (2015)

Income disparity and utilization of cardiovascular preventive care services among U.S. adults
por: Andi Shahu, et al.
Publicado: (2021)

Editorial: New Trends in the Renin-Angiotensin-Aldosterone System in Cardiovascular Disease
por: Ewa Szczepanska-Sadowska, et al.
Publicado: (2021)

Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration
por: Stephane Bourgeois, et al.
Publicado: (2021)

Physiologically relevant aspirin concentrations trigger immunostimulatory cytokine production by human leukocytes.
por: Regine Brox, et al.
Publicado: (2021)

The importance of timely diagnosis of aspirin-exacerbated respiratory disease for patient health and safety
por: Kathleen Buchheit, et al.
Publicado: (2020)

Endogenous cannabinoids may regulate chronic inflammation in aspirin-exacerbated respiratory disease
por: Joshua M. Levy
Publicado: (2020)

Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis
por: Daniel B. Spielman, et al.
Publicado: (2020)

Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease
por: Zhang JW, et al.
Publicado: (2017)

Aspirin-Based Organoiron Dendrimers as Promising Anti-Inflammatory, Anticancer, and Antimicrobial Drugs
por: Alaa S. Abd-El-Aziz, et al.
Publicado: (2021)

The effects of aspirin on the outcome of COVID-19: A systematic review and meta-analysis
por: Indra Wijaya, et al.
Publicado: (2021)